Médecins Sans Frontières in collaboration with Treatment Action Campaign Provincial Government of the Western Cape City of Cape Town University of Cape Town, Infectious Disease Epidemiology Unit Population = 500.000 Adult HIV prevalence: 32% in 2007 Highest TB case finding in the world: 1600/100.000 in 2006 Mostly informal housing; unemployment rate ± 60%; highly mobile population; pop. density > 6000/km2; electricity 76% of households; high rates of crime and sexual violence. 40% 35% 30% 25% 20% 15% 10% 5% 0% 1999 2000 2001 2002 2003 2004 2005 Mean Prevalence (95 % CI) 2006 2007 1998: Creation of TAC 1999: start of PMTCT programme 2000: HIV care pilot project (3 clinics) 2001: First patient started on ART 2004: National HIV plan leads to increased enrolment on ART 2009: 12,000 people started on ART at 9 sites ER1 :To develop a new model of care and to decentralise existing HIV/AIDS dedicated services -including ART- to five peripheral clinics Existing ARV clincis Extension 2006/07 Existing public health facilities • 3 community health centers (day hospitals) • 2 maternities (MTCT ante and peri-natal) • 8 local clinics (STI, FP, TB, <5 health, post-natal MTCT) • No hospital (under construction) • 3 hospices – 1 only for DR TB • “Home based care” NGOs CHC based ARV clincis New HIV clinics 2000: demonstrate feasibility of ART at primary health care level in resource-limited, peri-urban setting 2004: scaling up ART, TB/HIV integration, and integration into Provincial ART programme 2008: feasibility of achieving NSP targets, including “universal coverage” by 2011 80 % of needs ART coverage -> 800.000 to 1 million on Rx 80 % initiated and followed by nurses 50 % of children treated at PHC Reduction of HIV transmission by 50% 1998: 450 people tested for HIV in Khayelitsha Year 2003 2004 2005 2006 2007 Tested 16,024 20,576 26,681 32,383 32,069 Positive 4,928 6,474 8,804 9,691 8,749 %HIV +ve 31% 31% 33% 29.9% 27.3% Well functioning PMTCT programme since 1999 Vertical transmission = 3.5% in 2007 100% acceptance rate, formula feeding, AZT+NVP Integration of ART provision within MOU since 2004 Khayelitsha: IMR, 2001-2007 (Deaths of babies under 1 yr of age, out of 1,000 live births) 43 43 42 37 34 2001 2002 2003 2004 2005 31 30 2006 2007 450% 70000 400% 60000 350% 300% 50000 250% 40000 200% 30000 150% 20000 100% 10000 50% 0 0% 2001 2002 2003 Tot ART 2004 2005 Tot non ART 2006 2007 Ratio Ratio ART/nonART Total nmb of visits 80000 New patients 2006 2007 2008 2009 2010 2007 2008 2009 2010 2011 2,122 2,322 Target (new stage IV)* 3217 3485 3708 3847 3929 % needs covered 66% 67% Enrolled Remaining in care (%) 12 M 24 M 36 M 48 M 2001 2002 2003 83.4 84.9 86.4 81.2 79.5 81.7 78.0 78.3 77.3 73.8 75.4 73.5 2004 88.6 82.6 77.0 74.2 2005 87.8 82.6 77.6 2006 88.3 81.5 2007 86.6 Remaining in care (RIC) = (total initiated) – (deaths + loss to follow-up) Children < 14 years 250 2000 200 Adults started on ART Adults started on ART Adults 2500 1500 1000 100 50 500 0 150 0 2001 2002 2003 2004 2005 2006 2002 2003 2004 2005 2006 2007 Treatment naïve 33 37 63 98 127 101 Prior treatment or transferred in 6 24 39 64 56 35 2007 Treatment naïve 82 206 389 1,063 1,647 2,122 2,322 Prior treatment or transferred in 9 7 18 66 229 304 168 Median baseline CD4 and IQR by year (Adults) 200 150 105 100 73 50 48 112 85 41.5 0 2001 2002 2003 2004 2005 2006 100 200 150 Median time from date eligible to starting treatment 50 0 Time eligible for ARV's to treatment start Source: 2008, internal report 2002 2001 2000Louise Knight excludes outside values 2005 2004 2003 Year eligible for treatment 2006 2007 Expand providers: nurse based follow-up Simplify follow-up routines: Fast track systems (clubs, “chronic dispensing”) Limit number of follow-ups Improve functioning of administrative section Blood results, data entry Khayelitsha Monthly Total in Care May 2009 Total Adults Total Children TOTAL % of total Kuyasa 686 96 782 6,5 M. Goniwe 1000 45 1045 8,7 Michael M 3005 166 3171 26,5 Nolungile 2527 238 2765 23,1 Ubuntu 3702 278 3980 33,2 Site C Youth 87 87 0,7 Site B Youth 52 52 0,4 Town II 89 89 0,7 Khayelitsha 11148 823 11971 New Adults New Children TFI Total (New) Target % of total Kuyasa 33 4 3 37 25 10,8 M.Goniwe 38 1 4 39 35 11,3 Michael M 85 1 1 86 75 25,0 Nolungile 74 6 3 80 75 23,3 Ubuntu 75 2 6 77 100 22,4 Site C Youth 2 222 2 2 10 Site B Youth 8 0 8 15 Town II 15 0 0 15 ? 330 14 19 344 335 May 2009 Khayelitsha total 0,6 2,3 4,4 Facility based “clubs” ▪ Green clinic: patient stable, > 12 months on ARV’s, undetectable Community based “clubs” ▪ Functions : monthly support group meeting, clinical screening, drug distribution , data record. ▪ Management : community adherence counsellors ▪ Accountability : to the “mother clinic” ▪ Supply : drugs “patient’ labelled, nutritional support Diagnosed DR-TB cases All cases referred to Referral OPD Severe clinical condition and XDR-TB admitted for intensive phase (or until culture conversion) 4-6 months Others referred for clinic based treatment (intensive and continuation phase) Continuation phase treatment, clinic based Initiation of Treatment Quarter 1 2009 (prepared May 27th, 2009) Patients Started Tx = 52 Patients started Tx in Hospital = 9 Patients started Tx in Clinic = 43 Patients not Started Tx = 8 43 9 3 4 Being recalled Died before Treatment 1 Never Found Patients not started on treatment Clinic treatment In hospital Patients started on treatment Increase in HIV has been followed by increase in TB 70% of TB patients are HIV-infected in Khay. Increase in smear-TB and EPTB Increase in M/XDR-TB Need for TB/HIV integration 1800 Incidence per 100 000 Khayelitsha TB incidence 2002-2006 1600 1400 1200 1000 800 600 400 200 0 2002 All TB 2003 New smear (+)TB 2004 2005 New smear (-)TB 2006 EPTB Khayelitsha: VCT in TB services Proportion TB patients counselled Proportion accepted testing Proportion testing HIV + 2002 49% 89% 26% 2003 62% 84% 45% 2004 62% 87% 73% 2005 72% 91% 76% 2006 99% 95 % 67% 2007 99% 95 % 67% TB/HIV juxtaposition: 1 folder, different admin & clinicians Managerial integration: 1 folder & same admin, different clinicians and clinical pathway (Ubuntu). True TB/HIV integration: ARV delivery integrated within TB programme: one-stop service with same staff (admin & clinical) and patient flow (Town 2). 1. 2. 3. 4. 5. 6. 7. ART in a poor public sector setting is feasible. Increased enrolment on ART has resulted in decreased mortality. Saturation of large sites led to increased losses to follow-up. There is a need for decentralisation of ART to the most peripheral clinics. Success of nurse-based, doctor-supported strategy. Regulatory framework on the way. TB/HIV integrated services led to quicker diagnosis and treatment of both diseases in co-infected patients. Decentralized management of DR TB has led to increased diagnosis and number started on treatment. Collaboration between MSF, CoCT, and PGWC was an essential condition for success. Enrolment of children on ART Adherence in youth and pregnant women Enhanced adherence strategies Further decentralization Regulatory framework for decentralised nurse-based care DR- TB: new diagnostic and treatment options